Director, Field Health Economics & Outcomes Research (HEOR)

Nuvalent, Inc.(5 days ago)

RemoteFull TimeDirector$220,000 - $250,000Health Economics & Outcomes Research (HEOR)

About this role

Director of Health Economics & Outcomes Research at Nuvalent responsible for leading U.S. and global HEOR strategy to shape value evidence and enable patient access. The role drives RWE and HEOR study design, develops payer-facing economic and decision-support tools, supports launch planning, and educates the organization on HTA and reimbursement dynamics.

View Original Listing

Required Skills

HEOR Strategy
RWE
Budget Modeling
Cost-Effectiveness
Observational Methods
PROs
Biostatistics
Publication Writing
Payer Engagement
Vendor Management

+3 more

Qualifications

PhD
PharmD
MD/DO

About Nuvalent, Inc.

nuvalent.com

Nuvalent is a clinical‑stage, Cambridge‑based oncology company that designs precisely targeted small‑molecule therapies using deep chemistry know‑how and structure‑based drug discovery. Its pipeline focuses on selective kinase inhibitors aimed at genetically defined cancers (ALK, ROS1, HER2 and other kinase-driven solid tumors) with the goal of overcoming resistance and improving patient outcomes. Lead programs include NVL‑520, NVL‑655 and NVL‑330, and the company highlights an approach centered on precision medicine, structure‑guided design, and translational development.